HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis.

AbstractPURPOSE:
To establish a human leukocyte antigen (HLA) association in a homogeneous population of patients with pars planitis.
METHODS:
A strict set of inclusion parameters was established for the diagnosis of pars planitis. Forty patients with pars planitis who met these criteria underwent HLA analysis of class I and II phenotypes.
RESULTS:
HLA-B8 was present in 15 (37.5%) of 40 patients versus 85 (19.7%) of 431 controls (relative risk, 2.44; P = 0.011). HLA-B51 was present in 9 (22.5%) of 40 patients versus 51 (11.8%) of 431 controls (relative risk, 2.16; P = 0.049). HLA-DR2 was present in 27 (67.5%) of 40 patients versus 121 (28.0%) of 431 controls (relative risk, 5.32; P < 0.0001). HLA-DR2 has been associated with multiple sclerosis (MS). Exclusion of five patients with pars planitis in whom MS subsequently developed did not change the significance of these findings.
CONCLUSIONS:
The strongest association of pars planitis with HLA-DR2 and the temporal development of MS in some patients with pars planitis further supports an association between pars planitis and MS.
AuthorsS M Malinowski, J S Pulido, N E Goeken, C K Brown, J C Folk
JournalOphthalmology (Ophthalmology) Vol. 100 Issue 8 Pg. 1199-205 (Aug 1993) ISSN: 0161-6420 [Print] United States
PMID8341502 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-A Antigens
  • HLA-B Antigens
  • HLA-B8 Antigen
  • HLA-D Antigens
  • HLA-DR2 Antigen
Topics
  • Case-Control Studies
  • Female
  • HLA-A Antigens (genetics)
  • HLA-B Antigens (genetics)
  • HLA-B8 Antigen
  • HLA-D Antigens (genetics)
  • HLA-DR2 Antigen
  • Humans
  • Male
  • Multiple Sclerosis (etiology, immunology)
  • Pars Planitis (complications, immunology)
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: